Lista de obras -

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

artículo científico publicado en 2017

A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

artículo científico publicado en 2012

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

artículo científico publicado en 2016

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia

Amyloid pathology in the progression to mild cognitive impairment

artículo científico publicado en 2017

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2014

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

artículo científico publicado en 2015

Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly

artículo científico publicado en 2015

Brain structure and function as mediators of the effects of amyloid on memory

artículo científico publicado en 2015

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects

artículo científico publicado en 2011

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

scientific article published on 11 November 2019

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

scientific article published on 17 August 2016

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

artículo científico publicado en 2015

Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

artículo científico publicado en 2016

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

artículo científico publicado en 2013

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

artículo científico publicado en 2018

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

artículo científico publicado en 2012

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

artículo científico publicado en 2014

Different associations of white matter lesions with depression and cognition

artículo científico publicado en 2012

Early indications of future cognitive decline: stable versus declining controls

artículo científico publicado en 2013

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease

artículo científico publicado en 2013

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

artículo científico publicado en 2013

Emerging β-amyloid pathology and accelerated cortical atrophy

artículo científico publicado en 2014

Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking

artículo científico publicado en 2012

Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes

artículo científico publicado en 2011

Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment

artículo científico publicado en 2011

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

artículo científico publicado en 2016

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

artículo científico publicado en 2014

Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years

artículo científico publicado en 2011

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

artículo científico publicado en 2015

Nonlinear time course of brain volume loss in cognitively normal and impaired elders

artículo científico publicado en 2010

Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response

artículo científico publicado en 2013

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

artículo científico publicado en 2017

Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

artículo científico publicado en 2015

Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

artículo científico publicado en 2019

Serum tau and neurological outcome in cardiac arrest.

artículo científico publicado en 2017

Study partner-reported decline identifies cognitive decline and dementia risk

scientific article published on 13 November 2019

The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

artículo científico publicado en 2020

The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment

artículo científico publicado en 2013

The transitional association between β-amyloid pathology and regional brain atrophy

artículo científico publicado en 2014

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease

artículo científico publicado en 2017

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

artículo científico publicado en 2011

Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment

artículo científico publicado en 2014

Lista de obras de

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

Amyloid pathology in the progression to mild cognitive impairment

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly

Brain structure and function as mediators of the effects of amyloid on memory

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

Different associations of white matter lesions with depression and cognition

Early indications of future cognitive decline: stable versus declining controls

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

Emerging β-amyloid pathology and accelerated cortical atrophy

Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking

Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes

Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

Nonlinear time course of brain volume loss in cognitively normal and impaired elders

Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response

Plasma tau in Alzheimer disease

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

Serum tau and neurological outcome in cardiac arrest.

Study partner-reported decline identifies cognitive decline and dementia risk

The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment

The transitional association between β-amyloid pathology and regional brain atrophy

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment